These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 34273969)

  • 1. Role of autophagy-related protein in the prognosis of combined hepatocellular carcinoma and cholangiocarcinoma after surgical resection.
    Perng DS; Hung CM; Lin HY; Morgan P; Hsu YC; Wu TC; Hsieh PM; Yeh JH; Hsiao P; Lee CY; Li YC; Wang YC; Chen YS; Lin CW
    BMC Cancer; 2021 Jul; 21(1):828. PubMed ID: 34273969
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Axl and autophagy LC3 expression in tumors is strongly associated with clinical prognosis of hepatocellular carcinoma patients after curative resection.
    Hsu CC; Hsieh PM; Chen YS; Lo GH; Lin HY; Dai CY; Huang JF; Chuang WL; Chen YL; Yu ML; Lin CW
    Cancer Med; 2019 Jul; 8(7):3453-3463. PubMed ID: 31094090
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical features and outcomes of combined hepatocellular carcinoma and cholangiocarcinoma versus hepatocellular carcinoma versus cholangiocarcinoma after surgical resection: a propensity score matching analysis.
    Lin CW; Wu TC; Lin HY; Hung CM; Hsieh PM; Yeh JH; Hsiao P; Huang YL; Li YC; Wang YC; Shu CW; Chen YS
    BMC Gastroenterol; 2021 Jan; 21(1):20. PubMed ID: 33413162
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The clinical characteristics and prognostic factors of combined Hepatocellular Carcinoma and Cholangiocarcinoma, Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma after Surgical Resection: A propensity score matching analysis.
    Tang Y; Wang L; Teng F; Zhang T; Zhao Y; Chen Z
    Int J Med Sci; 2021; 18(1):187-198. PubMed ID: 33390787
    [No Abstract]   [Full Text] [Related]  

  • 5. Characteristics of combined hepatocelluar-cholangiocarcinoma and comparison with intrahepatic cholangiocarcinoma.
    Kim SH; Park YN; Lim JH; Choi GH; Choi JS; Kim KS
    Eur J Surg Oncol; 2014 Aug; 40(8):976-81. PubMed ID: 24909336
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autophagy-related gene LC3 expression in tumor and liver microenvironments significantly predicts recurrence of hepatocellular carcinoma after surgical resection.
    Lin CW; Chen YS; Lin CC; Lee PH; Lo GH; Hsu CC; Hsieh PM; Koh KW; Chou TC; Dai CY; Huang JF; Chuang WL; Chen YL; Yu ML
    Clin Transl Gastroenterol; 2018 Jul; 9(6):166. PubMed ID: 29961754
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Longterm prognosis of combined hepatocellular carcinoma-cholangiocarcinoma following liver transplantation and resection.
    Jung DH; Hwang S; Song GW; Ahn CS; Moon DB; Kim KH; Ha TY; Park GC; Hong SM; Kim WJ; Kang WH; Kim SH; Yu ES; Lee SG
    Liver Transpl; 2017 Mar; 23(3):330-341. PubMed ID: 28027599
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elevated neutrophil-to-lymphocyte ratio and predominance of intrahepatic cholangiocarcinoma prediction of poor hepatectomy outcomes in patients with combined hepatocellular-cholangiocarcinoma.
    Chiu TJ; Chen YJ; Kuo FY; Chen YY
    PLoS One; 2020; 15(12):e0240791. PubMed ID: 33306714
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combined hepatocellular carcinoma and cholangiocarcinoma: clinical features, treatment modalities, and prognosis.
    Yin X; Zhang BH; Qiu SJ; Ren ZG; Zhou J; Chen XH; Zhou Y; Fan J
    Ann Surg Oncol; 2012 Sep; 19(9):2869-76. PubMed ID: 22451237
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinicopathological characteristics of 15 patients with combined hepatocellular carcinoma and cholangiocarcinoma.
    Zuo HQ; Yan LN; Zeng Y; Yang JY; Luo HZ; Liu JW; Zhou LX
    Hepatobiliary Pancreat Dis Int; 2007 Apr; 6(2):161-5. PubMed ID: 17374575
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Integrated nomograms to predict overall survival and recurrence-free survival in patients with combined hepatocellular cholangiocarcinoma (cHCC) after liver resection.
    Wang T; Yang X; Tang H; Kong J; Shen S; Qiu H; Wang W
    Aging (Albany NY); 2020 Aug; 12(15):15334-15358. PubMed ID: 32788423
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adjuvant Transarterial chemoembolization does not influence recurrence-free or overall survival in patients with combined hepatocellular carcinoma and Cholangiocarcinoma after curative resection: a propensity score matching analysis.
    Liu WR; Tian MX; Tao CY; Tang Z; Zhou YF; Song SS; Jiang XF; Wang H; Zhou PY; Qu WF; Fang Y; Ding ZB; Zhou J; Fan J; Shi YH
    BMC Cancer; 2020 Jul; 20(1):642. PubMed ID: 32650743
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combined hepatocellular-cholangiocarcinoma: An analysis of clinicopathological characteristics after surgery.
    Zhang H; Yu X; Xu J; Li J; Zhou Y
    Medicine (Baltimore); 2019 Sep; 98(38):e17102. PubMed ID: 31567946
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinicopathological features and prognosis of combined hepatocellular carcinoma and cholangiocarcinoma after surgery.
    Lee SD; Park SJ; Han SS; Kim SH; Kim YK; Lee SA; Ko YH; Hong EK
    Hepatobiliary Pancreat Dis Int; 2014 Dec; 13(6):594-601. PubMed ID: 25475861
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combined hepatocellular-cholangiocarcinoma: which preoperative clinical data and conventional MRI characteristics have value for the prediction of microvascular invasion and clinical significance?
    Wang X; Wang W; Ma X; Lu X; Li S; Zeng M; Xu K; Yang C
    Eur Radiol; 2020 Oct; 30(10):5337-5347. PubMed ID: 32385649
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Meta-analysis of prognostic factors for overall survival and disease-free survival among resected patients with combined hepatocellular carcinoma and cholangiocarcinoma.
    Lv TR; Hu HJ; Ma WJ; Liu F; Jin YW; Li FY
    Eur J Surg Oncol; 2024 Jan; 50(1):107279. PubMed ID: 38000116
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patients' prognosis of intrahepatic cholangiocarcinoma and combined hepatocellular-cholangiocarcinoma after resection.
    Song P; Midorikawa Y; Nakayama H; Higaki T; Moriguchi M; Aramaki O; Yamazaki S; Aoki M; Teramoto K; Takayama T
    Cancer Med; 2019 Oct; 8(13):5862-5871. PubMed ID: 31407490
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sarcopenia predicts an adverse prognosis in patients with combined hepatocellular carcinoma and cholangiocarcinoma after surgery.
    Hou GM; Jiang C; Du JP; Yuan KF
    Cancer Med; 2022 Jan; 11(2):317-331. PubMed ID: 34866356
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognosis of hepatocellular carcinoma expressing cytokeratin 19: comparison with other liver cancers.
    Lee JI; Lee JW; Kim JM; Kim JK; Chung HJ; Kim YS
    World J Gastroenterol; 2012 Sep; 18(34):4751-7. PubMed ID: 23002345
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison between resection and transplantation in combined hepatocellular and cholangiocarcinoma.
    Song S; Moon HH; Lee S; Kim TS; Shin M; Kim JM; Park JB; Kwon CH; Kim SJ; Lee SK; Joh JW
    Transplant Proc; 2013 Oct; 45(8):3041-6. PubMed ID: 24157032
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.